Key points are not available for this paper at this time.
Long-term outcomes of patients with stage I human epidermal growth factor receptor 2 (HER2)-positive breast cancer receiving adjuvant trastuzumab emtansine (T-DM1) remain undefined, and prognostic predictors represent an unmet need.
Building similarity graph...
Analyzing shared references across papers
Loading...
Tarantino et al. (Thu,) studied this question.
www.synapsesocial.com/papers/68e62ea5b6db6435875c140d — DOI: https://doi.org/10.1200/jco.23.02170
Paolo Tarantino
Nabihah Tayob
Guillermo Villacampa
Journal of Clinical Oncology
Harvard University
University of Michigan
University of Chicago
Building similarity graph...
Analyzing shared references across papers
Loading...